Sign in
4

Changes in Ownership

Maze Therapeutics, Inc. Filed Acc 0001676170-26-000002

Options or other derivatives

  • Chief Executive Officer acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Coloma Jason V · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 150,000 D
2026-03-02 Grant or award : show line 2 in the form Restricted Stock Units +75,000 75,000 D
Loading xslF345X05/form4-03032026_090313.xml…